ESR1 and gastric cancer: One of the ER-targeting agents, tamoxifen, has an anti-proliferative effect on GC cell lines.[9] Stimulation of GC cell lines with 17β-estradiol (E2) promoted proliferation, up-regulated ER-α36 mRNA expression, and repressed cell apoptosis.